RECRUITING

MCW Master Predict (Profile Related Evidence Determining Individualized Cancer Therapy)

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The study is an observational trial for patients undergoing cancer-related interventions and therapy at Medical College of Wisconsin Cancer Center. Projects under this protocol will use patient data that will be collected both retrospectively and prospectively. It will also enable prospective sample collection for specific cancer-related studies.

Official Title

Medical College of Wisconsin Master Predict (Profile Related Evidence Determining Individualized Cancer)

Quick Facts

Study Start:2022-12-19
Study Completion:2027-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05802069

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Subjects aged 18 years and older who were previously or are currently receiving care for a cancer-related condition at MCW/FH.
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Kristina Jacobs
CONTACT
414-955-3643
kjacobs@mcw.edu
Medical College of Wisconsin Cancer Center Clinical Trials Office
CONTACT
866-680-0505
cccto@mcw.edu

Principal Investigator

Sameem Abedin, MD
PRINCIPAL_INVESTIGATOR
Medical College of Wisconsin
Razelle Kurzrock, MD
PRINCIPAL_INVESTIGATOR
Medical College of Wisconsin
Mary M. Horowitz, MD, MS
PRINCIPAL_INVESTIGATOR
Medical College of Wisconsin

Study Locations (Sites)

Froedtert Hospital and the Medical College of Wisconsin
Milwaukee, Wisconsin, 53226
United States

Collaborators and Investigators

Sponsor: Sameem M. Abedin, MD

  • Sameem Abedin, MD, PRINCIPAL_INVESTIGATOR, Medical College of Wisconsin
  • Razelle Kurzrock, MD, PRINCIPAL_INVESTIGATOR, Medical College of Wisconsin
  • Mary M. Horowitz, MD, MS, PRINCIPAL_INVESTIGATOR, Medical College of Wisconsin

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-12-19
Study Completion Date2027-12

Study Record Updates

Study Start Date2022-12-19
Study Completion Date2027-12

Terms related to this study

Additional Relevant MeSH Terms

  • Cancer